| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/24/2005 | US20050043558 Thiols and disulphides and their use in producing substrates |
| 02/24/2005 | US20050043528 Enterococcus faecalis polynucleotides and polypeptides |
| 02/24/2005 | US20050043520 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/24/2005 | US20050043518 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 02/24/2005 | US20050043514 Monoclonal antibody recognizing phosphatidylinositol-3,4-diphosphate |
| 02/24/2005 | US20050043512 Human glioma antigen originating in testis |
| 02/24/2005 | US20050043511 G-protein coupled receptor lustr2 and uses thereof |
| 02/24/2005 | US20050043421 Reducing concentration of amine polymerization catalyst; polyurethane foams |
| 02/24/2005 | US20050043414 Trityl-type compounds and their use |
| 02/24/2005 | US20050043377 Thioflavin derivatives for use in the antemortem diagnosis of alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 02/24/2005 | US20050043293 Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof |
| 02/24/2005 | US20050043288 Composition and method for marking procaine penicillin |
| 02/24/2005 | US20050043275 MORE STABLE REACTION OF GLUCOSE WITH A BORONIC ACID COMPOUND SUCH AS 9,10-BISN-(BORONOBENZYL)-N-(3-(METHYACRYLAMIDO) PROPYLAMINO)METHYLANTHRACENE; qualitative, quantitative analysis for diabetic tests |
| 02/24/2005 | US20050043265 High affinity RNA ligands of basic fibroblast growth factor |
| 02/24/2005 | US20050043254 contacting MT 0039 protein or the transformant expressing the protein with a candidate for screening an agent capable of controlling an activity of the protein |
| 02/24/2005 | US20050043227 Incubating mixture of HIF-2 alpha or a fragment thereof and at least one molecule, allowing binding between HIF-2 alpha or fragment thereof and molecule, isolating molecule binding to HIF-2 alpha , or fragment thereof and determining ability of molecule to inhibit development of pulmonary hypertension |
| 02/24/2005 | US20050043224 Administering to patient a pharmaceutical preparation comprising at least one chemoprotective inducing agent and a vehicle for delivering chemoprotective inducing agent to cells lining hair follicles, in an amount and for a time effective to reduce or prevent hair loss |
| 02/24/2005 | US20050043096 Biometric broadband gaming system and method |
| 02/24/2005 | US20050042774 Bioassay comprising immobilized biopolymer for use in medical prognostic and diagnostics; immunoassay |
| 02/24/2005 | US20050042773 Optically-and electrically-addressable concentrators of biological and chemical materials |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050042769 Biomolecule handling method and machine using an array dispenser |
| 02/24/2005 | US20050042767 Method and device for preparing sample slide |
| 02/24/2005 | US20050042765 Apparatus comprising diagnostic strips and switching components for use in analysis of biological fluids |
| 02/24/2005 | US20050042762 fluorinated chloroalkanes; sampling exhaled air during and after stressful activities, quantitative analysis comparing peak signals from gas chromatography coupled with mass spectrometry |
| 02/24/2005 | US20050042761 Method for identifying at risk cardiovascular disease patients |
| 02/24/2005 | US20050042759 Test method for determining etch performance of coated substrate |
| 02/24/2005 | US20050042742 Apparatus which determines ovulation via measurement of changes in ion concentration of eccrine sweat; fertility and reproductive disorders |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042724 Sodium-dependent phosphate cotransporter (NAPTR) for use tool in identifying modulators for treatment and prevention of cell proliferative, nervous system and cardiovascular disorders |
| 02/24/2005 | US20050042720 Modified g-protein for use as tool in identifying modulator for treatment of cell proliferative disorders; mimetics; high throughput assay |
| 02/24/2005 | US20050042718 Using transgenic cells to generate monoclonal antibodies for use in immunodiagnostics and tissue directed therapy |
| 02/24/2005 | US20050042713 Characterising polypeptides |
| 02/24/2005 | US20050042709 Fructosyl amino acid oxidase acts on glycated hemoglobin in presence of tetrazolium compound and sodium azide |
| 02/24/2005 | US20050042707 Using variation in visible spectra of light emitting moieties as diagnostic tool in detection of preferential analytes in fluids; blood testing; urinalysis |
| 02/24/2005 | US20050042705 Methods for the identification of inhibitors of mannosyltransferase as antibiotics |
| 02/24/2005 | US20050042704 Entrapped binding protein as biosensors |
| 02/24/2005 | US20050042702 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 02/24/2005 | US20050042701 Bioconjugates; metabolites; kits; bioavailbility; pharmacokinetics |
| 02/24/2005 | US20050042700 Compositions and methods for monitoring breast cancer treatment |
| 02/24/2005 | US20050042698 Using mass/charge signature of unbound heme to diagnose malarial parsite infection |
| 02/24/2005 | US20050042697 Generating trangenic cell for use as diagnostic tool in blood group determination |
| 02/24/2005 | US20050042696 Systems and methods for detection of analytes in biological fluids |
| 02/24/2005 | US20050042695 For detecting and analyzing oxidized polypeptides, nucleic acids, lipids, and polysaccharides; kits; neurodegenerative/neoplastic/vascular/autoimmune disorders |
| 02/24/2005 | US20050042694 Detection of protein conformations in single cells |
| 02/24/2005 | US20050042693 Using bispecific immunoglobulin to monitor ceruloplasmin concentration and screen for copper metabolism defects |
| 02/24/2005 | US20050042692 Using laser capture microdissection and immunofluorescence to identify regions preferential RNA expression; disease imaging and gene expression profiles |
| 02/24/2005 | US20050042691 Methods for identifying active compounds |
| 02/24/2005 | US20050042689 Using presence of membrane associated muscarinic adrenergic receptor type 3 (M3R) specific antibody in bodily fluids as diagnostic and /prognostic indicator of autoimmune diseases |
| 02/24/2005 | US20050042688 Using cytoskeletal protein expression profiles as diagnostic indicator of infection, viral disease and/or cancer; biomolecular signature a nd disease detection |
| 02/24/2005 | US20050042686 Neurotoxic amino acid or neurotoxic derivative thereof associated with neurological disorders |
| 02/24/2005 | US20050042685 Using bispecific antibodies comprising magnetic particle to separate and identify tumorigenic testicular tissue in solution |
| 02/24/2005 | US20050042682 Using protein-matching as tool in diagnosis of metabolic disorders |
| 02/24/2005 | US20050042681 Methods and formulations for diagnosing, monitoring, staging and treating heart failure |
| 02/24/2005 | US20050042680 Single chain antigen-binding polypeptides for polymer conjugation |
| 02/24/2005 | US20050042679 Determining susceptibility of partially atrophied thymus to reactivation; regeneration of thymus through sex steroid ablation; regenerative medicine |
| 02/24/2005 | US20050042678 Method of using physiological markers to estimate cardiovascular risk |
| 02/24/2005 | US20050042676 Contacting sample with lysine selective agent to cap epsilon -amino group, digesting sample to produce peptide fragments, deactivating cleavage reagent, deblocking/deprotecting, then recovering fragments; solid phase synthesis; kits |
| 02/24/2005 | US20050042671 Modulation of angiogenesis |
| 02/24/2005 | US20050042665 Using fluorescent biopolymers as tools in detection of preferential nucleotide sequences; gene expression analysis; genomics |
| 02/24/2005 | US20050042659 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 02/24/2005 | US20050042658 Array-based epitope-captured antibody display |
| 02/24/2005 | US20050042655 Using hematopoietoic regulatory related polypeptide (HEMA) for use in diagnosis, treatment and prevention of hematopoietic disorders |
| 02/24/2005 | US20050042653 Human transport protein homologs |
| 02/24/2005 | US20050042652 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics |
| 02/24/2005 | US20050042650 EN2 gene, diagnostic and therapeutic uses thereof |
| 02/24/2005 | US20050042649 Arrayed biomolecules and their use in sequencing |
| 02/24/2005 | US20050042648 Vitro sorting method |
| 02/24/2005 | US20050042644 Mobility-modified nucleobase polymers and methods of using same |
| 02/24/2005 | US20050042642 Using breast cancer gene expression as diagnostic indicator of cell proliferative disorders; antitumor agents |
| 02/24/2005 | US20050042624 Tumor antigen |
| 02/24/2005 | US20050042623 Microarray comprising an immobilized addressed collection of polypeptide-tagged molecules for use as tool in evaluating and monitoring intracellular and extracellular biological activities |
| 02/24/2005 | US20050042622 Using microarray chips for gene expression monitoring, profiling, library screening and genotyping |
| 02/24/2005 | US20050042618 Fluorescent resonance energy transfer probes |
| 02/24/2005 | US20050042615 Colloids formed at interface between streams of reducing agent and metal salt; suface enhanced raman scattering (SER(R)s) |
| 02/24/2005 | US20050042613 Nucleic acids having expression differentails between hepatoblastoma and normal liver |
| 02/24/2005 | US20050042610 Method and support for biological analysis using oligonucleotides comprising a marker capable of enzymatic activation |
| 02/24/2005 | US20050042609 Using variation in signal ratios from fluorescent probes to detect chromosomal aberration; prenatal diagnosis of genetic disorders |
| 02/24/2005 | US20050042607 Parkin protein as ubiquitin ligase |
| 02/24/2005 | US20050042602 Monitoring immunologic, Hematologic and inflammatory diseases |
| 02/24/2005 | US20050042600 Using complex formed with carboxymethylcysteine substituted peptide as diagnostic indicator of viral infection; diagnosing cell proliferative and infectious disorders; immunodiagnostics |
| 02/24/2005 | US20050042599 Using complex formed with carboxymethylcysteine substituted peptide as diagnostic indicator of viral infection; diagnosing cell proliferative and infectious disorders immunodiagnostics |
| 02/24/2005 | US20050042596 Process for examining membrane enclosed biocompartments |
| 02/24/2005 | US20050042595 Banking of multipotent amniotic fetal stem cells |
| 02/24/2005 | US20050042455 Coating for various types of substrate and method for the production thereof |
| 02/24/2005 | US20050042363 Method for fabrication of biochips with a macroporous polymer substrate |
| 02/24/2005 | US20050042308 Soft capsules containing mint oil with analgesics, antiinflammatory agents ; complex |
| 02/24/2005 | US20050042231 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
| 02/24/2005 | US20050042224 Methods and products related to metabolic interactions in disease |
| 02/24/2005 | US20050042222 Methods of diagnosing thyroid carcinoma |
| 02/24/2005 | US20050042221 Purified antibody directed against modified beta -amyloid peptide comprising malondialdehyde adduct; medical research involving amyloid precursor protein (APP)-metabolism; enzyme-linked immunosorbent assays |
| 02/24/2005 | US20050042214 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis |
| 02/24/2005 | US20050042209 Enhancing the induction apoptosis in a MUC1 expressing cancer cell by a pro-apoptotic drugs; antiproliferative agents |
| 02/24/2005 | US20050042205 Purification and cloning of receptors for luteinizing hormone, choriogonadotropin, follicle stimulating hormone, and/or thyroid stimulating hormone; fertility, breast or prostate cancer, benign prostatic hypertrophy, vasomotor instability, osteoporosis, and polycystic ovarian disease; genetic engineering |
| 02/24/2005 | US20050042200 Administering to mammal interleukin-11 to increase leptin levels; free of dividing adipocytes; obesity and diabetes treatment |
| 02/24/2005 | US20050042148 Use of electrochemical sensor in a reactor for oxidizing and/or reducing a gas sample to facilitate detection with improved sensitivity and reduced response time |
| 02/24/2005 | US20050042143 Plastic plate and plastic plate assembly |
| 02/24/2005 | US20050042141 Hydrogen sensor such as for fuel cell; includes a water-repelling filter covering the gas intake for use in high humidity environments; difference in electrical resistance between the sensing and temperature-compensating elements by using heat of combustion generated from gas and catalyst |
| 02/24/2005 | US20050042139 Pre-concentrator and concentrator; microfluidics; detection of gases such as air pollutants; configured as a multiple fluid or gas chromatograph; faster, more compact and efficient than conventional and/or portable gas chromatographs |